Prioritizing risk-based management, data science, smart automation, standards, and patient optionality are critical for the industry to keep up with market changes. The recent FDA guidance that encourages ‘pragmatic trials’ in specific scenarios is a move in the right direction.
The post Carving a Path Toward Pragmatic Innovation in Clinical Trials appeared first on MedCity News.
